ERA: Empowered Relief Delivered by Nurses

Sponsor
Washington State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05934435
Collaborator
American Society for Pain Management Nursing (Other)
170
2
14

Study Details

Study Description

Brief Summary

This study will investigate effects of a psychoeducation pain management skills intervention on adults with persistent pain by training a cohort of American Society for Pain Management Nursing (ASPMN) nurses to deliver and it [Empowered Relief (ER)], as a single-session video-conferenced program. The primary objective is to evaluate the effects of ASPMN nurse-provided ER versus waitlist control (WLC) on pain catastrophizing, pain bothersomeness, pain intensity, pain interference, sleep disturbance, physical function, depression, anxiety, and social isolation for patients with persistent pain. Secondarily, feasibility and acceptability of the ER program will be assessed through recruitment and retention data and qualitative satisfaction data.

Condition or Disease Intervention/Treatment Phase
  • Other: Empowered Relief
N/A

Detailed Description

Design: This study will be conducted as a randomized controlled trial comparing effects of ER to a WLC of participants with persistent pain when ER is provided by ER-trained ASPMN nurses. The secondary aims of feasibility and acceptability will use qualitative descriptive methods.

Participants: Participants (N=170) will be adults aged 18 and above years with self- reported or clinically diagnosed persistent pain. Participants will be recruited at clinical sites identified by ER-trained nurses and can be self or clinician referred. Participants will complete an online eligibility form to screen for inclusion and exclusion criteria. Inclusion criteria: pain >3 months more than half the time, English fluency, ability to attend a one-time web-based class and complete web-based surveys, age > 18 years. Exclusion criteria: Previous participation in ER class, cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators.

Procedures: Twenty ASPMN nurses will receive ER training facilitated by Stanford Pain Relief Innovations Lab. ER- trained nurse providers will be ASPMN-member nurses of any clinical background. ASPMN nurses will be invited to apply to become a trainer with the following expectations: ability to fully participate in a live, online, 2-day ER instructor training, able to fluently complete instructor training and deliver the ER program in English, commitment to deliver 1-3 live, online, 2-hour ER programs for patient participants, and willingness to complete post-program surveys after each session they deliver reporting on number of participants and any barriers encountered. Recruitment will occur through ASPMN-related mechanisms of communication, including its website, national officers and directors, newsletter, research group, national committees, chapter leadership and listserv.

After meeting eligibility criteria and completing informed consent, study participants will be asked to complete a baseline survey of demographics and health variables (as outlined in Table 1) and then randomized 1:1 to one of two unblinded study groups: ER and WLC. Participants randomized to the ER group will complete a HIPAA compliant, password protected Zoom ER class delivered by an ER-trained ASPMN nurse. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
170 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
After randomized 1:1 to one of two unblinded study groups: ER and Wait-List Control, participants randomized to the ER group will complete the ER class. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.After randomized 1:1 to one of two unblinded study groups: ER and Wait-List Control, participants randomized to the ER group will complete the ER class. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.
Masking:
Single (Outcomes Assessor)
Masking Description:
Biostatistician will be blinded to ER treatment group or Wait-list Control group.
Primary Purpose:
Treatment
Official Title:
Addressing Pain Care Inequities With Empowered Relief Delivered by ASPMN Nurses: A Randomized Controlled Trial
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Empowered Relief treatment

Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

Other: Empowered Relief
psycho-educational pain skills training
Other Names:
  • ER
  • Other: Wait-list Control

    Participants randomized to the Wait-list Control group will continue their usual pain care for 2 months and complete surveys to compare with the experimental treatment group. After serving as controls, they will be invited to attend the 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

    Other: Empowered Relief
    psycho-educational pain skills training
    Other Names:
  • ER
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Pain Catastrophizing [Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.]

      Measured by self-report

    Secondary Outcome Measures

    1. Change in Pain Intensity [Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.]

      0-10 Pain severity scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age > 18 years

    • pain >3 months more than half the time

    • English fluency

    • ability to attend a one-time web-based class and complete web-based surveys.

    Exclusion criteria:
    • Previous participation in ER class

    • cognitive impairment

    • non-English speaking

    • psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Washington State University
    • American Society for Pain Management Nursing

    Investigators

    • Principal Investigator: Marian Wilson, PhD, Washington State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marian Wilson, Associate Professor, Washington State University
    ClinicalTrials.gov Identifier:
    NCT05934435
    Other Study ID Numbers:
    • 20013-001
    First Posted:
    Jul 7, 2023
    Last Update Posted:
    Jul 7, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marian Wilson, Associate Professor, Washington State University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 7, 2023